SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Statement

19 May 2008 13:30

RNS Number : 7780U
Flomerics Group PLC
19 May 2008
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATESAUSTRALIACANADA OR JAPAN

FOR IMMEDIATE RELEASE

19th May 2008

FLOMERICS GROUP PLC

Statement re: Posting of Offer Document following Unsolicited Offer

 

 

The Board of Directors of Flomerics Group PLC ("Flomerics" or the "Company") notes the statement by Mentor Graphics, Inc. ("Mentor") that it has posted an offer document to Flomerics shareholders in respect of its unsolicited offer for all the outstanding shares and stock options in Flomerics at a price of 104 pence per share payable in cash (the "Offer"). 

 

The Board of Directors of Flomerics continues to believe the Offer materially undervalues the Company and is actively engaged in assessing other alternatives available to the Company, including potential interest expressed by a number of other parties, which are the subject of ongoing discussions. Shareholders are therefore strongly urged to ignore any documents or announcements that may be made or issued by Mentor or its advisers and not to sell their valuable Flomerics shares.

David Mann, Chairman of Flomerics commented: "We have previously stated that the Offer, which is unsolicited, has been considered by the Board of Flomerics, in conjunction with its independent adviser, and we have unanimously concluded that it does not reflect the true value of Flomerics shares. As such, the Offer does not carry the recommendation of the Flomerics Board of Directors as we do not believe it is in the best interests of Flomerics shareholders." 

The Board of Directors intends to write to its shareholders in due course to explain its current position with regard to the Mentor Offer.

Any discussions with other interested parties continue to be at an early stage and there can be no certainty that an alternative offer will be forthcoming. However, shareholders are strongly recommended to take no action at this stage. A further announcement will be made in due course.

 

Enquiries: 

 

Flomerics Group PLC

Gary Carter

Keith Butcher

Tel: 020 8487 3000

Jefferies International Ltd (Financial adviser to Flomerics)

Andres Pieczanski

Sarah McNicholas

Tel: 020 7029 8000

Oriel Securities Limited (Nominated Adviser and Corporate Broker to Flomerics)

Andrew Edwards

Michael Shaw

Tel: 020 7710 7600

Citigate Dewe Rogerson

Ginny Pulbrook

Seb Hoyle

Tel: 020 7638 9571

 

Jefferies International Limited ("Jefferies International"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Jefferies International or for giving advice in relation to such matters.

Oriel Securities Limited ("Oriel Securities"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Oriel Securities or for giving advice in relation to such matters.

 

 Dealing Disclosure Requirements 

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Flomerics, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Nestor, they will be deemed to be a single person for the purpose of Rule 8.3. 

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Flomerics by a potential offeror or by Flomerics, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction. 

 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk. 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

 

Terms in quotation marks are defined in the Code, which can also be found on the Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPGUUAPAUPRGPB
Date   Source Headline
2nd Jun 20087:00 amRNSStatement re Unsolicited Offe
30th May 20084:40 pmRNSOffer Update
30th May 20082:36 pmRNSRule 2.10 Announcement
30th May 20089:30 amRNSAdditional Listing
29th May 20081:41 pmRNSResult of AGM
28th May 20082:15 pmRNSResult of AGM
28th May 20082:11 pmRNSPosting of Defence Document
28th May 20087:00 amRNSOffer Update
27th May 20087:00 amRNSQ1 Trading Update
19th May 20081:30 pmRNSStatement
19th May 20087:00 amRNSOffer Document Posted
16th May 20087:00 amRNSAnnual General Meeting
13th May 20081:20 pmRNSRule 8.3-Flomerics Plc
13th May 200812:45 pmRNSRule 8.3- Flomerics Group Plc
13th May 20089:35 amRNSRule 2.10 and TVR
12th May 20081:49 pmRNSAdditional Listing
9th May 20088:48 amRNSOffer Rejection
9th May 20088:37 amRNSOffer for Flomerics Group plc
30th Apr 20084:23 pmRNSHolding(s) in Company
30th Apr 200811:14 amRNSAdditional Listing
29th Apr 20087:01 amRNSFinal Results
18th Apr 200812:06 pmRNSAdditional Listing
15th Apr 200810:41 amRNSDirectorate Change
10th Apr 20082:51 pmRNSHolding(s) in Company
10th Apr 20087:00 amRNSTotal Voting Rights
27th Mar 20087:02 amRNSUpdate
19th Mar 200812:58 pmRNSHolding(s) in Company
19th Mar 200810:11 amRNSHolding(s) in Company
18th Mar 20083:59 pmRNSAdditional Listing
18th Mar 20087:30 amRNSHolding(s) in Company
17th Mar 200811:27 amRNSHolding(s) in Company
14th Mar 20083:17 pmRNSHolding(s) in Company
3rd Mar 20087:00 amRNSAdditional Listing
28th Feb 20082:37 pmRNSDirector/PDMR Shareholding
27th Feb 200810:50 amRNSDirector/PDMR Shareholding
22nd Feb 20085:31 pmRNSDirector/PDMR Shareholding
21st Feb 200812:19 pmRNSGrant of Options
9th Jan 20087:00 amRNSTrading Statement
20th Dec 20077:02 amRNSDisposal
19th Dec 200712:36 pmRNSHolding(s) in Company
3rd Dec 200712:00 pmRNSDirectorate Change
27th Sep 200711:23 amRNSAdditional Listing
27th Sep 20079:41 amRNSHolding(s) in Company
19th Sep 20077:02 amRNSInterim Results
14th Sep 20075:03 pmRNSHolding(s) in Company
15th Aug 20072:27 pmRNSAIM Rule 26
13th Jul 20077:00 amRNSTrading Statement
12th Jul 20075:07 pmRNSHolding(s) in Company
5th Jul 200711:41 amRNSTotal Voting Rights
21st Jun 20075:52 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.